skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment

Original Research

(2763) Views  (788) Full article downloads

Authors: Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis

Published Date June 2008 Volume 2008:4(3) Pages 627 - 630
DOI: http://dx.doi.org/10.2147/TCRM.S2515

Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis

Department of Neurology, University of Ioannina School of Medicine, Greece

Objective: To aid in the timely diagnosis of patients who present with clinically isolated syndrome (CIS).

Patients and methods: We studied 25 patients (18 women, 7 men), originally presented in our clinic with a CIS suggestive of multiple sclerosis (MS). All patients underwent the full investigation procedure including routine tests, serology, cerebrospinal fluid (CSF) examinations, evoked potentials (EPs), and magnetic resonance imaging (MRI) of brain and cervical spinal cord. Patients were imaged at baseline, and every three months thereafter up to a year.

Results: The CIS was consisted of optic neuritis in 12 cases, incomplete transverse myelitis (ITM) in 7 cases, Lhermitte sign in 2 cases, internuclear ophthalmoplegia (INO) in 2 cases, mild brainstem syndrome in 1 case, and tonic-clonic seizures in 1 case. Using the baseline and three-month scans 18/25 (72%) patients developed definite MS in one year of follow up while 7 (28%) had no further findings during this observation period. Immunomodulatory treatments were applied to all definite MS patients.

Conclusion: In light of new treatments available, MRIs at 3 month intervals are helpful to obtain the definite diagnosis of MS as early as possible.

Keywords: multiple sclerosis, clinically isolated syndrome, optic neuritis, transverse myelitis








Readers of this article also read:

Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Towards a new standard of perioperative fluid management
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug
Optimization of single-walled carbon nanotube solubility by noncovalent PEGylation using experimental design methods
Zinc oxide nanoparticles as selective killers of proliferating cells
Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial
Critical illness outcome study: an observational study of protocols and mortality in intensive care units
Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in Côte d'Ivoire